<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two cases of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> and marked retention of <z:chebi fb="0" ids="31696">indocyanine green</z:chebi> (ICG) are described </plain></SENT>
<SENT sid="1" pm="."><plain>Since <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="0" ids="17659">uridine diphosphate</z:chebi> (<z:chebi fb="15" ids="17659">UDP</z:chebi>)-glucuronyl transferase activities were depressed in their liver, the patients seemed to have <z:chebi fb="0" ids="16990">bilirubin</z:chebi> metabolism similar to that in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the ICG fractional disappearance rates of the cases were rather low (0.018 and 0.019) compared to the rates reported for <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggest that the patients had a new <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> which results in constitutional <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> and ICG intolerance </plain></SENT>
</text></document>